Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcium Kunihiro refers to a line of over-the-counter (OTC) nutritional supplements developed and manufactured by Kokando Pharmaceutical under the 'Kunihiro' brand. These products are primarily indicated for calcium supplementation to prevent deficiency and support bone health, particularly during periods of increased physiological demand such as growth, pregnancy, and lactation, or for individuals with fragile bones. The formulations typically utilize calcium salts, such as calcium carbonate, calcium hydrogen phosphate, or calcium L-aspartate, to provide elemental calcium necessary for bone mineralization and neuromuscular function. Some versions, such as 'New Calcium Kunihiro,' are combination products that include Cholecalciferol (Vitamin D3) to enhance intestinal calcium absorption and Magnesium carbonate to support mineral balance and metabolic processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Calcium Kunihiro.